Advancing Science, Improving Lives

Transforming Ideas into Trusted Therapies

Driving Quality, Delivering Care

Rising with Excellence, Rising for Patients

Delivering Versatility, Building Accessibility

Better Medicines for Better Outcomes

Advancing Science, Improving Lives

Transforming Ideas into Trusted Therapies

Driving Quality, Delivering Care

Rising with Excellence, Rising for Patients

Delivering Versatility, Building Accessibility

Better Medicines for Better Outcomes

Overview

At Rising Pharmaceuticals, our commitment to improving patient outcomes drives everything we do. Our Research and Development division focuses on developing affordable, high-quality medicines and diverse healthcare solutions for our patients and business partners.

Making life better for everyone we serve

We are dedicated to enhancing lives through rigorous quality testing, cutting-edge research, and an unwavering commitment to excellence in every product we develop.

Our R&D Mission

Pioneering research and fostering innovative therapeutic solutions that respond to the ever-evolving needs of patients and healthcare providers.

Strategic Partnerships

Strengthen R&D capabilities and expand the portfolio through global collaborations.

Development of High-Quality Medicines

Ensure quality, safety, and accessibility across generic and specialty products.

Differentiated Product Portfolio

Build a robust portfolio with emphasis on niche and complex formulations, including injectables.

"At Rising, generic drug development is a quiet act of service — where curiosity is currency, 'too difficult' starts a conversation, and every molecule we crack becomes a treatment someone can finally afford."

Sandeep Mhetre
Chief Scientific Officer

"At Rising, generic drug development is a quiet act of service — where curiosity is currency, 'too difficult' starts a conversation, and every molecule we crack becomes a treatment someone can finally afford."

Sandeep Mhetre
Chief Scientific Officer

Key Areas of Research

Our research focuses on therapeutic and technological areas that are critical for improving patient health across the globe.

Niche Generics

Rising focuses on niche, low-competition products that are often neglected by manufacturers, thereby significantly improving accessibility to patients in need.

Complex Generics

We specialize in developing complex generics, including sustained-release formulations, injectables, ophthalmic products, and combination therapies.

505(b)(2) NDA Products

We develop 505(b)2 products to bring modified versions of existing drugs to the market faster and with greater benefit to patients.

Our Strength in Numbers

Rising’s commitment to excellence is reflected in our impressive track record and capabilities.

R&D Professionals

0 +

Skilled scientific team driving product development

Manufacturing sites

0 +

Extensive manufacturing network supporting scalable production and consistent quality supply

Commercial products

0 +

A broad portfolio of commercialised high-quality products

Pipeline products

0 +

Robust pipeline of upcoming complex products

Our Strength in Numbers

Rising’s commitment to excellence is reflected in our impressive track record and capabilities.

R&D Professionals

0 +

Skilled scientific team driving product development

Manufacturing sites

0 +

Extensive manufacturing network supporting scalable production and consistent quality supply

Commercial products

0 +

A broad portfolio of commercialised high-quality products

Pipeline products

0 +

Robust pipeline of upcoming complex products

At Rising, diverse minds don't just coexist — they collide, collaborate, and create impact that reaches far beyond the lab.

At Rising, diverse minds don't just coexist — they collide, collaborate, and create impact that reaches far beyond the lab.

R&D Capabilities

Our R&D facilities are equipped with cutting-edge technologies that enable us to develop high-quality generics efficiently and effectively. We employ a comprehensive approach to research that includes:

Pre-Formulation & Formulation Development

Strong capabilities in developing complex formulations and achieving bioequivalence with innovator products, with a dedicated oncology facility for potent API handling.

Advanced Analytical & in-vitro testing Lab

The advanced analytical laboratory focuses on solid-state characterisation, including polymorphism, microscopy, thermal analysis, and other IVRT techniques, to ensure that all our products meet rigorous quality standards.

Stability Testing

Stability studies are conducted in accordance with ICH guidelines to ensure the product’s integrity.

Regulatory Affairs

Meeting regulatory requirements across global markets including US FDA, EMA, and other national regulatory agencies with comprehensive ANDA and DMF preparation.

Clinical Trials & Bioequivalence Studies

Robust clinical trials and bioequivalence studies using extensive in-vitro testing, PBPK modelling and statistical tools to resolve complex bioequivalence challenges.

Data management and digital team

Strong team dedicated to data integrity and utilizing AI tools to enhance operational efficiency, compliance, and traceability across all development stages.

Commitment to Quality

Quality is at the heart of everything we do. From concept to commercialization, Rising Pharmaceuticals adheres to the most stringent standards of quality assurance and control. Our products undergo rigorous testing at every stage to ensure they meet the highest levels of safety, efficacy, and consistency.

Development Quality Assurance (DQA)

Our DQA team maintains quality oversight by working closely with regulatory, QA, CMO sites and R&D teams throughout the development process.

GMP Compliance

All products are manufactured in state-of-the-art GMP facilities, embodying our dedication to regulatory compliance and superior quality.

Quality Management Systems

We employ proven strategies including quality event reviews, risk-based vendor audits, and FDA inspection responses.

Commitment to Quality

Quality is at the heart of everything we do. From concept to commercialization, Rising Pharmaceuticals adheres to the most stringent standards of quality assurance and control. Our products undergo rigorous testing at every stage to ensure they meet the highest levels of safety, efficacy, and consistency.

Development Quality Assurance (DQA)

Our DQA team maintains quality oversight by working closely with regulatory, QA, CMO sites and R&D teams throughout the development process.

GMP Compliance

All products are manufactured in state-of-the-art GMP facilities, embodying our dedication to regulatory compliance and superior quality.

Quality Management Systems

We employ proven strategies including quality event reviews, risk-based vendor audits, and FDA inspection responses.

LEADERSHIP TEAM

Nand Desai is dedicated to driving strategic transformations and integrations within the organization, leveraging his extensive experience across all functional groups to ensure successful execution. He holds a BBA from the University of Michigan – Ross School of Business. Before joining Rising, Nand was engaged in private equity at H.I.G. Capital, where he focused on middle-market opportunities. He began his career as an Analyst in the M&A group at Greenhill & Co., gaining valuable experience in financial analysis and advisory services.

Test Member

Test Menber

TEST MEMBER

Test Member

Nand Desai is dedicated to driving strategic transformations and integrations within the organization, leveraging his extensive experience across all functional groups to ensure successful execution. He holds a BBA from the University of Michigan – Ross School of Business. Before joining Rising, Nand was engaged in private equity at H.I.G. Capital, where he focused on middle-market opportunities. He began his career as an Analyst in the M&A group at Greenhill & Co., gaining valuable experience in financial analysis and advisory services.